Investing.com -- DuPont (NYSE: DD) reported first-quarter results that exceeded analyst expectations and raised its full-year guidance, sending shares up 4.6% premarket following the announcement.

The company posted adjusted earnings per share of $0.55, beating the analyst consensus of $0.49 by $0.06. Revenue reached $1.68 billion, surpassing the $1.66 billion estimate and marking a 4% increase from the prior-year period. Organic sales grew 2% YoY, while a 2% currency benefit contributed to the overall revenue gain.

DuPont guided second-quarter adjusted EPS to approximately $0.59, slightly above the $0.58 consensus, with revenue expected at around $1.8 billion, in line with analyst estimates. For full-year 2026, the company raised its adjusted EPS guidance to a range of $2.35 to $2.40, with a midpoint of $2.375, exceeding the $2.27 consensus. Full-year revenue guidance of $7.16 billion to $7.22 billion also topped the $7.1 billion estimate, with the midpoint at $7.19 billion.

"We delivered a strong start to the year, exceeding our financial guidance through disciplined commercial and operational execution," said Lori Koch, DuPont Chief Executive Officer. "Our teams remained focused on our customers and delivered organic growth, margin expansion, and double-digit adjusted EPS growth, along with solid cash flow generation in the quarter."

The Healthcare & Water Technologies segment reported net sales of $806 million, up 6% from the year-ago period, with 3% organic growth. Healthcare Technologies sales rose in the high-single digits on strength in medical packaging and biopharma. The Diversified Industrials segment generated $875 million in sales, up 3%, though organic sales were flat as strength in aerospace and automotive was offset by construction market weakness.

Operating EBITDA increased 15% to $414 million, with margins expanding 230 basis points to 24.6%.